Search

Background: Inflammation and oxidative stress are believed to play an important role in the pathogenesis of Alzheimer's disease (AD). Tenuifolin (TEN) is a natural neuroprotective compound extracted from Polygala tenuifolia Willd, which may improve cognitive symptoms.Objective: This study was designed to evaluate the protective effect of TEN on inflammatory and oxidative stress induced by amyloid-β (Aβ)42 oligomers in BV2 cells, and to explore the underlying mechanisms.Methods: We conducted cell viability assays to estimate drug toxicity and drug effects on cells. Quantitative real-time polymerase chain reaction and enzyme-linked immunosorbent assays were performed to detect the release of inflammatory factors. Nitric oxide (NO) assays were used to measure the degree of oxidative stress. Western blot and immunofluorescence analysis were used to explore the influence of TEN on the nuclear factor-κB (NF-κB) pathway.Results: Pretreatment of BV2 microglial cells with TEN inhibited the release of tumor necrosis factor-α, interleukin-6, and interleukin-1β, alleviated NO-induced oxidative stress by inhibiting the expression of inducible nitric oxide synthase and cyclo-oxygenase-2, and protected SH-SY5Y cells from the toxicity induced by the medium conditioned by BV2 cells previously exposed to Aβ42 oligomers. Moreover, TEN suppressed upstream activators of NF-κB, as well as NF-κB translocation to the nucleus in BV2 microglial cells.Conclusion: This study demonstrates that TEN can protect SH-SY5Y cells from Aβ42 oligomer-induced microglia-mediated inflammation, and oxidative stress by downregulating the NF-κB signaling pathway. [ABSTRACT FROM AUTHOR]

Isolated mechanical systems—e.g., those floating in space, in free-fall, or on a frictionless surface—are able to achieve net rotation by cyclically changing their shape, even if they have no net angular momentum. Similarly, swimmers immersed in “perfect fluids” are able to use cyclic shape changes to both translate and rotate even if the swimmer-fluid system has no net linear or angular momentum. Finally, systems fully constrained by direct nonholonomic constraints (e.g., passive wheels) can push against these constraints to move through the world. Previous work has demonstrated that the displacement induced by these shape changes corresponds to the amount of constraint curvature that the gaits enclose. Properly assessing or optimizing the utility of a gait also requires considering the time or resources required to execute it: A gait that produces a small displacement per cycle, but that can be executed in a short time, may produce a faster average velocity than a gait that produces more displacement, but takes longer to complete a cycle at the same instantaneous effort. In this paper, we consider gaits under two instantaneous measures of effort. For each of these costs, we demonstrate that fixing the average instantaneous cost to a unit value allows us to transform the effort costs into time-to-execute costs for any given gait cycle. We then illustrate how the interaction between the constraint curvature and these costs leads to characteristic geometries for optimal cycles, in which the gait trajectories resemble elastic hoops distended from within by internal pressures. [ABSTRACT FROM AUTHOR]

Presents a rigorous field theoretical analysis of slow wave mode propagation in coplanar waveguide (CPW) metal-insulator-semiconductor (MIS) transmission lines with a laterally confined doping profile. Investigation of the two types of transmission line structures; Investigation of the effect of the abrupt transition between MIS and CPW.

Background: Alzheimer's disease (AD) exerts a heavy burden on China. Substantial factors are found associated with high expenditure of AD in high-income countries. To date, few studies have been conducted in China.Objective: This study aimed to analyze the associated factors of the total annual costs of AD in China.Methods: Data were drawn from a multi-center, cross-sectional, socioeconomic study on the costs of AD conducted in China from October 2015 to March 2016. Generalized linear model (GLM) using gamma distribution with a log-link function was employed to examine the associated factors of the total cost.Results: Univariate analysis showed that the demographic and clinical characteristics of AD patients and their caregivers had a substantial impact on the total cost. In GLM analysis, age, monthly household income, AD severity, number of comorbidities, and treatment with memantine were associated with higher expenditure, while the use of a nursing home/care facility was associated with lower expenditure. The mean annual costs for patients with severe dementia were almost twice as high as those for patients with mild dementia (US$ 25,601 versus US$ 13,387, p < 0.001). The mean total cost of AD patients with at least five comorbidities (US$ 38,348) was almost three times than those with no comorbidities (US$ 13,744).Conclusion: In China, AD severity and comorbidities were the most critical factors impacting the total cost. Optimizing care patterns, delaying disease progression, and managing comorbidities comprehensively could decrease the heavy burden of AD. [ABSTRACT FROM AUTHOR]

Background: Alzheimer's disease (AD) is the most common type of dementia. International multilateral cost-of-illness (COI) studies have revealed that the cost of treating this disease is huge, which places a significant burden on patients' families and their healthcare systems. However, no such studies have been conducted in China. This study estimates the monetary costs of patients with AD in mainland China.Methods: This study planned to start in October 2015 and to finish in March 2016. It covered 30 provincial, municipal, and autonomous regions in mainland China. The sites and research centres in each region were selected randomly. The participating sites include Tier 3 hospitals, psychiatric hospitals, geriatric hospitals, nursing homes, and residences. More than 2500 patients with AD and their caregivers from all of the 81 research centres will be enrolled to fulfil the calculated sample size. The monetary costs of AD, which include direct medical costs, direct non-medical costs, and indirect costs, are being collected using the electronic medical record system and residence health system at each site; face-to-face interviews are being performed when necessary. Descriptive statistics will be used to summarise the patient characteristics and generalised linear models will be developed to calculate the costs.Results: The main findings will include national and per patient annual monetary costs of AD in China.Conclusions: To the best of our knowledge, this is the first large-scale cluster-randomized observational study to estimate the economic burden of AD in Chinese patients. The methodology used was based on China's current healthcare system and is suitable for the purpose of the study. Because the burden of AD on patients, families, healthcare providers, and society is substantial and increasing, it is important and necessary to understand the economic burden caused by this disease.Trial Registration: Our trial was retrospectively registered on ClinicalTrials.gov, NCT02694445 , registered on 02/26/2016. [ABSTRACT FROM AUTHOR]